UNIQUE EXPERTISE
Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
UNIQUE CAPABILITIES
We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.
OUR PUBLICATIONS
We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.
NEWS
Icelandic Research Data Contributes to Landmark Fibromyalgia Genetics Study
In a landmark study published in Nature Medicine (https://www.nature.com/articles/s41591-026-04492-6), an international team of researchers have identified new genetic risk factors associated with fibromyalgia suggesting that the biological basis of the condition is...
AMGEN DECODE GENETICS ANNOUNCES APPOINTMENT OF DANÍEL F. GUDBJARTSSON AS SITE HEAD
deCODE genetics, a subsidiary of the global biotechnology company Amgen, today announced the appointment of Daníel F. Guðbjartsson, Ph.D. as Associate Vice President and Site Head. In this role, Dr. Guðbjartsson will lead site operations for deCODE genetics, further...
Award by the American Society of Human Genetics
At its Annual meeting in October 2017 in Orlando, the American Society of Human Genetics (ASHG), presented Dr. Kári Stefánsson, founder and CEO of deCODE genetics, with the William Allan Award. The award, the top prize given by the society, recognizes a scientist for substantial and far-reaching scientific contributions to human genetics. The ASHG has distributed video footage from the award ceremony. The introduction is given by Professor Mark Daly of Harvard University.